Page last updated: 2024-10-24

chlorambucil and Ureteral Diseases

chlorambucil has been researched along with Ureteral Diseases in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Ureteral Diseases: Pathological processes involving the URETERS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Guillou, M1
Richard, F1
L'Hénaff, F1
Ferriere, JM1
Durand, J1
Lacert, P1
Küss, R1

Other Studies

1 other study available for chlorambucil and Ureteral Diseases

ArticleYear
Bilateral ureteral necrosis in a child with dermatomyositis.
    European urology, 1980, Volume: 6, Issue:3

    Topics: Adrenal Cortex Hormones; Child; Chlorambucil; Dermatomyositis; Dilatation; Female; Humans; Necrosis;

1980